venetoclax,azacitidine,emavusertib,ibrutinib
roche,curis,abbvie,Janssen
['emavusertib', 'lymphoma', 'biomarker']
curis at #eha22! come see us at booth 880. and tomorrow don't miss our posters on takeaim lymphoma (p1121), novel biomarker development (p473) and emavusertib in pcns lymphoma (p1298).
#cris #takeaim #biotechnology 
NASDAQ: CRIS